Development of New Catalytic Asymmetric Routes towards a Cost-Driving Building Block of Nirmatrelvir

Robert Szpera,Shanjun Huang,Harriet A. M. Fenton,William Waddington,Adam E. S. Gymer,Ian Moses,Julia Buck,Heather Ingram,Steven J. Fussell,Robert Walton,Charles S. Shanahan,Sarah L. Aleshire,Juliana M. S. Robey,Hanuman P. Kalmode,Michel C. Nuckols,Nageswara R. Kalikinidi,Venumadhav Janganati,Sipak Joyasawal,Chanaka M. Amarasekarage,Chris Senanayake,B. Frank Gupton

DOI: https://doi.org/10.26434/chemrxiv-2024-51d8j

2024-01-31

Abstract:Nirmatrelvir is an inhibitor of SARS-CoV-2 main protease and is the active ingredient in PaxlovidTM. Nirmatrelvir presents a significant synthetic challenge, in no small part due to a cost-driving lactam containing fragment with two stereogenic centers. Our goal was to help decrease the cost of nirmatrelvir, by developing a scalable low-cost synthesis of this fragment, avoiding use of cryogenic conditions reported in the initial route. Herein we disclose three catalytic asymmetric routes to-wards this fragment, via i) chiral Lewis acid (copper) catalysis, ii) chiral Brønsted base organocatalysis and iii) chiral bifunctional hydrogen-bond-donor organocatalysis.

Chemistry

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to reduce the cost of Nirmatrelvir (a drug used to treat COVID - 19 and one of the active ingredients in Paxlovid), especially by developing a less - costly and large - scale - producible synthetic route to prepare an important fragment in Nirmatrelvir - lactam fragment 3 with two chiral centers. The existing synthetic methods are costly due to the need for low - temperature conditions and excessive LiHMDS, which restricts the global supply of Nirmatrelvir. Therefore, the researchers aim to develop a new catalytic asymmetric synthetic route that does not require low - temperature conditions in order to reduce costs and improve production efficiency.

To achieve this goal, three different catalytic asymmetric synthesis strategies are explored in the paper:

1. **Copper - catalyzed Lewis acid catalysis**: Use the copper - catalyzed asymmetric Michael addition reaction to set the α - and γ - chiral centers of the target molecule 3.
2. **Chiral Brønsted base catalysis**: Generate the target product by controlling the asymmetric Michael addition reaction through a chiral Brønsted base catalyst.
3. **Bifunctional hydrogen - bond - donor catalysis**: Use a bifunctional hydrogen - bond - donor catalyst to control the Michael addition reaction of nitro compounds and attempt to control the α - and γ - chiral centers simultaneously.

These strategies aim to avoid using expensive low - temperature conditions and excessive reagents, thereby reducing the synthesis cost and achieving large - scale production.